More sequencing data and studies on the mechanism of cancer occurrence and clinical trials about NOD2 gene, such as inflammation and immune disease area [25, 26], are needed to further reveal the specific mechanism of action in kidney cancer areas. This evidence concerns the gene NOD2 and kidney cancer.